Supported By: Provention Bio, Inc.

Program Description

This innovative and interactive program will explore screening and staging of type 1 diabetes (T1D) in high-risk patients, then comprehensive treatment to delay progression to clinical T1D, including pharmacotherapy, patient/family education, and so much more. The goal of this program is to arm clinicians with best practices and tools that can be immediately applied in practice to improve your patient care. Please join us!

Speakers

Kevin C. Herold MD
Yale University
Professor of Immunobiology and Internal Medicine
New Haven, CT

Mark A. Atkinson PhD
The University of Florida
Departments of Pathology and Pediatrics
Director, UF Diabetes Institute
Gainesville, FL

Kimber Simmons MD, MPH/MSPH
Barbara Davis Center for Diabetes/University of Colorado School of Medicine
Assistant Professor of Pediatrics
Aurora, CA